Fresenius pulls out of Akorn takeover over data integrity

BERLIN, April 22 (Reuters) - German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after its own investigation found data integrity breaches at the U.S. generic drug maker.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.